Cargando…
Diverse evolutionary pathways challenge the use of collateral sensitivity as a strategy to suppress resistance
Drug resistance remains a major obstacle to malaria control and eradication efforts, necessitating the development of novel therapeutic strategies to treat this disease. Drug combinations based on collateral sensitivity, wherein resistance to one drug causes increased sensitivity to the partner drug...
Autores principales: | Mandt, Rebecca EK, Luth, Madeline R, Tye, Mark A, Mazitschek, Ralph, Ottilie, Sabine, Winzeler, Elizabeth A, Lafuente-Monasterio, Maria Jose, Gamo, Francisco Javier, Wirth, Dyann F, Lukens, Amanda K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695565/ https://www.ncbi.nlm.nih.gov/pubmed/37737220 http://dx.doi.org/10.7554/eLife.85023 |
Ejemplares similares
-
Identification of
Collateral Sensitivity to Dihydroorotate Dehydrogenase Inhibitors
in Plasmodium falciparum
por: Ross, Leila Saxby, et al.
Publicado: (2018) -
Elucidating the path to Plasmodium prolyl-tRNA synthetase inhibitors that overcome halofuginone resistance
por: Tye, Mark A., et al.
Publicado: (2022) -
Using in Vitro Evolution and Whole
Genome Analysis To Discover Next Generation Targets for Antimalarial Drug Discovery
por: Luth, Madeline R., et al.
Publicado: (2018) -
Evolutionary stability of collateral sensitivity to antibiotics in the model pathogen Pseudomonas aeruginosa
por: Barbosa, Camilo, et al.
Publicado: (2019) -
In Vitro Resistance Selections for Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors Give Mutants with Multiple Point Mutations in the Drug-binding Site and Altered Growth
por: Ross, Leila S., et al.
Publicado: (2014)